JP2010501604A5 - - Google Patents

Download PDF

Info

Publication number
JP2010501604A5
JP2010501604A5 JP2009525948A JP2009525948A JP2010501604A5 JP 2010501604 A5 JP2010501604 A5 JP 2010501604A5 JP 2009525948 A JP2009525948 A JP 2009525948A JP 2009525948 A JP2009525948 A JP 2009525948A JP 2010501604 A5 JP2010501604 A5 JP 2010501604A5
Authority
JP
Japan
Prior art keywords
medicament according
glucose level
glucose
ramipril
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009525948A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010501604A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/007160 external-priority patent/WO2008025450A1/en
Publication of JP2010501604A publication Critical patent/JP2010501604A/ja
Publication of JP2010501604A5 publication Critical patent/JP2010501604A5/ja
Pending legal-status Critical Current

Links

JP2009525948A 2006-08-28 2007-08-14 グルコースレベルを低下させる方法 Pending JP2010501604A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84085006P 2006-08-28 2006-08-28
PCT/EP2007/007160 WO2008025450A1 (en) 2006-08-28 2007-08-14 Methods of lowering glucose levels

Publications (2)

Publication Number Publication Date
JP2010501604A JP2010501604A (ja) 2010-01-21
JP2010501604A5 true JP2010501604A5 (enExample) 2010-09-24

Family

ID=38578487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009525948A Pending JP2010501604A (ja) 2006-08-28 2007-08-14 グルコースレベルを低下させる方法

Country Status (12)

Country Link
US (1) US20080188538A1 (enExample)
EP (1) EP2059242A1 (enExample)
JP (1) JP2010501604A (enExample)
KR (1) KR20090042976A (enExample)
CN (1) CN101573110A (enExample)
AU (1) AU2007291602B2 (enExample)
BR (1) BRPI0716411A2 (enExample)
CA (1) CA2661598A1 (enExample)
IL (1) IL197189A0 (enExample)
MX (1) MX2009002091A (enExample)
NO (1) NO20090926L (enExample)
WO (1) WO2008025450A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
CA2026686A1 (en) * 1989-10-30 1991-05-01 Werner Tschollar Method for preventing onset of type ii diabetes employing an ace inhibitor
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
WO2003032965A2 (en) * 2001-10-17 2003-04-24 King Pharmaceuticals Research And Development, Inc Use of ace inhibitors for reducing type 2 diabetes in high risk patients
US20050065203A1 (en) * 2001-10-17 2005-03-24 Salim Yusuf Method of reducing type 2 diabetes in high risk patients
CA2458288A1 (en) * 2003-03-11 2004-09-11 Institut De Cardiologie De Montreal / Montreal Heart Institute Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure

Similar Documents

Publication Publication Date Title
CA2829101C (en) Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia
JP5707490B2 (ja) ２型糖尿病の処置
CN100577171C (zh) 治疗重度心力衰竭的药物
CN102056603A (zh) 决奈达隆用于预防持续性心房纤颤
CN107157999A (zh) 川芎嗪硝酮衍生物在预防和治疗糖尿病并发症疾病中的应用
JP6198013B2 (ja) Ｓｇｌｔ２阻害薬と抗高血圧薬との組み合わせ
US20140128402A1 (en) Pharmaceutical combination
ITRM20100233A1 (it) Associazione di inibitori della xantina ossidasi e metformina e loro uso.
US10918612B2 (en) Combinations with 2-aminoethanesulfonic acid
WO2006130901A1 (en) Control of metabolic abnormalities
JP2008189679A (ja) ２型糖尿病治療用の併用医薬
EP2386300A1 (en) Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality in patients having a first recurrence of atrial fibrillation or atrial flutter
CN101869562B (zh) 左旋氨氯地平复方药物制剂
CN101269027A (zh) 阿替洛尔缓释滴丸及其制备方法
Chandana et al. A review on clinical aspects of amiodarone
CN101773500B (zh) 抗高血压的药物组合物
WM Cheng Management of atrial fibrillation: focus on the role of dronedarone
EP2387996A1 (en) Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation
CN103432128B (zh) 一种盐酸吡格列酮缓释微丸制剂含药层的组配方法
EP2374457B1 (en) Antihypertensive pharmaceutical composition
US20080188538A1 (en) Methods of lowering glucose levels
TUCKER Colesevelam Found to Lower Glucose in Diabetes
EP2431033A1 (en) Dronedarone for preventing cardiovascular hospitalization or mortality in patients with lone atrial fibrillation
WO2006005415A3 (en) Use of l-carnitine and glucose for the treatment of cardiovascular diseases
TW201103544A (en) Pharmaceutical composition and application thereof